JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
Clinical trial NCT06581380 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06581380
- Sponsor
- JenKem Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-16
- Primary completion
- 2027-11-16
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.